Restinal en es it fr

Restinal Brand names, Restinal Analogs

Restinal Brand Names Mixture

  • No information avaliable

Restinal Chemical_Formula


Restinal RX_link

No information avaliable

Restinal fda sheet

Restinal msds (material safety sheet)

Restinal Synthesis Reference

No information avaliable

Restinal Molecular Weight

309.469 g/mol

Restinal Melting Point

< 25 oC

Restinal H2O Solubility

Soluble as HCl salt

Restinal State


Restinal LogP


Restinal Dosage Forms

Tablets (oral, 1 mg)

Restinal Indication

Used for the symptomatic treatment of parkinsonism.

Restinal Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Restinal Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Restinal side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Restinal Patient Information

Restinal Organisms Affected

Humans and other mammals